Menopause Treatment Market Size in the 7MM was ~USD 10,970 Million in 2023, is expected to ...
DelveInsight's “Menopause Market Insights, Epidemiology and Market Forecast – 2034” report delivers an in-depth understanding ...
Managed Healthcare Executive8 天
The Future of Neurokinin-Targeted Therapies in Patients With VMS
A panelist discusses how neurokinin-targeted therapies can be strategically combined with existing treatments to address multiple vasomotor symptoms (VMS) while highlighting their positive impact on ...
Managed Healthcare Executive15 天
Neurokinin-Targeted Therapies and Their Incorporation Into Clinical Guidelines
A panelist discusses how the potential of neurokinin-targeted therapies to provide targeted symptom relief with fewer side ...
Nature1 个月
Nature Research Intelligence Topics
Nature Research Intelligence Topics enable transformational understanding and discovery in research by categorising any document into meaningful, accessible topics. Read this blog to understand ...
来自MSN3 个月
New weight loss drug target reduces appetite and burns calories without sickness
The discovery could lead to a new treatment for millions of people with obesity and type 2 diabetes who do not respond well to current treatments.
Frontiers5 年
Kisspeptin and Polycystic Ovary Syndrome
KND-y neuron, Kisspeptin-Neurokinin B-Dynorphin Neuron; kp, Kisspeptin; GnRH, Gonadotropin-Releasing Hormone; LH, Luteinizing Hormone; FSH, Follicular-stimulating Hormone; PR, Progesterone receptor; ...